Fund closureConfirmed 29 August 2025
Arctic closes biotech fund after four years
Arctic Asset Management closed Arctic Aurora Biotech Select on 29 August 2025, slightly more than four years after the fund was launched in 2021.
The fund was established as a dedicated biotechnology strategy and a more targeted complement to Arctic Aurora LifeScience. It invested globally in a combination of innovative early-stage companies and larger, established biotechnology businesses, primarily in the US and Europe.
Arctic said the fund had achieved its investment objective but had not grown to a size that made it commercially viable to continue. The board therefore concluded that maintaining the fund under the prevailing market conditions was no longer in investors’ best interests.
Investors could redeem or switch their holdings until 28 August 2025. Any remaining units were automatically redeemed as part of the liquidation the following day.
Share this article